Product Information
TRULICITY 3 MG/0.5 ML PEN is a brand product labeled by Eli Lilly and Company, priced at $487.5022 per ML under NDC 00002223680. Its NADAC has been published 302 times since Dec 23, 2020.
Strength
3 mg/.5mL
Manufacturer
Eli Lilly and CompanyNDC
00002223680
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
DULAGLUTIDEApproval Type
Biologic (BLA)
FDA Application
BLA125469On Market Since
9/3/2020
Pharmacological Classes
Price Statistics
The NADAC for TRULICITY 3 MG/0.5 ML PEN has been published 302 times since Dec 23, 2020, and over the history we have for it it has risen 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $487.5022 per ML |
|---|---|
| All-time high | $487.7390 (May 13, 2026) |
| All-time low | $382.2959 (Dec 23, 2020) |
| 52-week high | $487.7390 |
| 52-week low | $478.1755 |
| Median price | $447.9192 |
| Average price | $450.5041 |
| Largest weekly change | +5.9% (Jan 13, 2021) |
| Weeks tracked | 302 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dulaglutide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dulaglutide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
GLP-1 Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRULICITY 3 MG/0.5 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TRULICITY 3 MG/0.5 ML PEN, manufactured by Eli Lilly and Company, is $487.5022 per ML (NDC 00002223680), effective Sep 30, 2026.
How has the price of TRULICITY 3 MG/0.5 ML PEN changed over time?
Over the history we have for it, the NADAC for TRULICITY 3 MG/0.5 ML PEN has risen 27.5%. It has been tracked across 302 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for TRULICITY 3 MG/0.5 ML PEN?
Since Dec 23, 2020, the NADAC for TRULICITY 3 MG/0.5 ML PEN has ranged from a low of $382.2959 (Dec 23, 2020) to a high of $487.7390 (May 13, 2026), with a median of $447.9192 per ML.
Are there cheaper alternatives to TRULICITY 3 MG/0.5 ML PEN?
No other NADAC-published product currently shares the active ingredient and strength of TRULICITY 3 MG/0.5 ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRULICITY 3 MG/0.5 ML PEN?
TRULICITY 3 MG/0.5 ML PEN (NDC 00002223680) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.